Cannabis use and risk of lung cancer: a case–control study
暂无分享,去创建一个
A. Hansell | M. Weatherall | M. Harwood | R. Beasley | S. Aldington | L. Beckert | A. Pritchard | G. Robinson | B. Cox | Geoffrey Robinson
[1] G. Stevens,et al. Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for Survival , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] H. Morgenstern,et al. Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.
[3] K. Straif,et al. Risk of Lung Cancer and Past Use of Cannabis in Tunisia , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] C. Laezza,et al. Cannabinoids and cancer: pros and cons of an antitumour strategy , 2006, British journal of pharmacology.
[5] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[6] W. Hall,et al. Cannabinoids and cancer: causation, remediation, and palliation. , 2005, The Lancet. Oncology.
[7] A. Sasco,et al. A case–control study of lung cancer in Casablanca, Morocco , 2002, Cancer Causes & Control.
[8] M. Guzmán,et al. Cannabinoids: potential anticancer agents , 2003, Nature Reviews Cancer.
[9] G. Burci. World Health Organization (WHO): Framework Convention on Tobacco Control* , 2003, International Legal Materials.
[10] B. Martin,et al. Clinical Consequences of Marijuana , 2002, Journal of clinical pharmacology.
[11] C. Lathers. Endocrine Disruptors: A New Scientific Role for Clinical Pharmacologists? Impact on Human Health, Wildlife, and the Environment , 2002, Journal of clinical pharmacology.
[12] E. Mark,et al. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. , 2001, Cancer research.
[13] Li Zhu,et al. Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1 , 2000, The Journal of Immunology.
[14] Li Zhu,et al. D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway , 2000 .
[15] E. Mark,et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. , 1999, Journal of the National Cancer Institute.
[16] M. Machtay,et al. Lung and aero-digestive cancers in young marijuana smokers. , 1999, Tumori.
[17] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[18] Wayne Hall,et al. Adverse effects of cannabis , 1998, The Lancet.
[19] M. Roth,et al. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. , 1998, Journal of the National Cancer Institute.
[20] M. Roth,et al. Airway inflammation in young marijuana and tobacco smokers. , 1998, American journal of respiratory and critical care medicine.
[21] M. Roth,et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. , 1997, Chest.
[22] M. Renneker,et al. A cytologic evaluation of sputum in marijuana smokers. , 1994, Journal of Family Practice.
[23] L. Metsch,et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. , 1994, Journal of psychoactive drugs.
[24] A. Achour,et al. Facteurs étiologiques du cancer bronchique primitif en Tunisie. , 1993 .
[25] M. Hsairi,et al. [Etiologic factors in primary bronchial carcinoma in Tunisia]. , 1993, La Tunisie medicale.
[26] Tzu-chin Wu,et al. Tar, CO and Δ 9-THC delivery from the 1st and 2nd halves of a marijuana cigarette , 1991, Pharmacology Biochemistry and Behavior.
[27] G. Swan,et al. Cytomorphologic features of sputum samples from marijuana smokers , 1991, Diagnostic cytopathology.
[28] J. Rose,et al. Pulmonary hazards of smoking marijuana as compared with tobacco. , 1988, The New England journal of medicine.
[29] D. Tashkin,et al. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. , 1987, The American review of respiratory disease.
[30] R. Peto. Influence of dose and duration of smoking on lung cancer rates. , 1986, IARC scientific publications.
[31] J. Robinson,et al. A comparison of tar, carbon monoxide and pH levels in smoke from marihuana and tobacco cigarettes. , 1982, Canadian journal of public health = Revue canadienne de sante publique.
[32] E. Wei,et al. Mutagenic activity of marihuana smoke condensates. , 1979, Cancer letters.
[33] D. Geddes,et al. The natural history of lung cancer: a review based on rates of tumour growth. , 1979, British journal of diseases of the chest.
[34] M. Boutet,et al. Chronic inhalation of marijuana and tobacco in dogs: pulmonary pathology. , 1976, Research communications in chemical pathology and pharmacology.
[35] G. B. Gori,et al. On the Carcinogenicity of Marijuana Smoke , 1975 .
[36] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[37] R. Doll,et al. Mortality in Relation to Smoking: Ten Years' Observations of British Doctors , 1964, British medical journal.